Duration of extended adjuvant therapy with neratinib in early-stage HER2+ breast cancer after trastuzumab-based therapy: Exploratory analyses from the phase III ExteNET trial
Gnant, Michael, Iwata, Hiroji, Bashford, Anna Elizabeth, Separovic, Robert, Murias, Adolfo, Vicente, Elena, Means-Powell, Julie Ann, Mayer, Ingrid A., Senecal, Francis Mark, Hui, Rina, De Boer, Richard H., Chiu, Joanne, Armstrong, Anne, Ruiz, Amparo, Bryce, Richard, Ye, Yining, Chan, Arlene
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article